Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations

Tamra Lysaght, Ian H. Kerridge, Douglas Sipp, Gerard Porter, Benjamin J. Capps

Résultat de recherche: Articleexamen par les pairs

27 Citations (Scopus)

Résumé

Cell and tissue-based products, such as autologous adult stem cells, are being prescribed by physicians across the world for diseases and illnesses that they have neither been approved for or been demonstrated as safe and effective in formal clinical trials. These doctors often form part of informal transnational networks that exploit differences and similarities in the regulatory systems across geographical contexts. In this paper, we examine the regulatory infrastructure of five geographically diverse but socio-economically comparable countries with the aim of identifying similarities and differences in how these products are regulated and governed within clinical contexts. We find that while there are many subtle technical differences in how these regulations are implemented, they are sufficiently similar that it is difficult to explain why these practices appear more prevalent in some countries and not in others. We conclude with suggestions for how international governance frameworks might be improved to discourage the exploitation of vulnerable patient populations while enabling innovation in the clinical application of cellular therapies.

Langue d'origineEnglish
Pages (de-à)261-273
Nombre de pages13
JournalJournal of Bioethical Inquiry
Volume14
Numéro de publication2
DOI
Statut de publicationPublished - juin 1 2017

Note bibliographique

Publisher Copyright:
© 2017, Journal of Bioethical Inquiry Pty Ltd.

ASJC Scopus Subject Areas

  • Health(social science)
  • Health Policy

Empreinte numérique

Plonger dans les sujets de recherche 'Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations'. Ensemble, ils forment une empreinte numérique unique.

Citer